MedicalOncology

This slideshow gives a good summary of the diagnosis of lung cancer.  

A short audio-visual presentation  

A presentation for palliative care and oncology  

 

<p>Case discussion with Drs. Tom Hensing of in Chicago &amp; David Jackman in Boston, discussing practical issues around molecular marker testing &amp; recommended treatments for first line &amp; maintenance therapy for an ex-smoker with a lung adenocarcinoma.</p>  

<p>Case discussion with Drs. Tom Hensing of in Chicago &amp; David Jackman in Boston, discussing practical issues around molecular marker testing &amp; recommended treatments for first line &amp; maintenance therapy for an ex-smoker with a lung adenocarcinoma.</p>  

<p>Q&amp;A session wtih Dr. Ezra Cohen, medical oncologist from the University of Chicago, after his expert overview of head/neck cancer and specific discussion of role of post-operative chemotherapy.</p>  

<p>Q&amp;A session wtih Dr. Ezra Cohen, medical oncologist from the University of Chicago, after his expert overview of head/neck cancer and specific discussion of role of post-operative chemotherapy.</p>  

<p>Dr. Ezra Cohen, medical oncologist from the University of Chicago, provides expert overview of head/neck cancer and specific discussion of role of post-operative chemotherapy.</p>  

<p>Dr. Ezra Cohen, medical oncologist from the University of Chicago, provides expert overview of head/neck cancer and specific discussion of role of post-operative chemotherapy.</p>  

<p <p>Q&amp;A session following presentation on history &amp; general approaches for radiation, with focus on head/neck cancer, by Dr. Alex Lin, Assistant Professor of Radiation Oncology at the Univ. of Pennsylvania.</p </p>  

<p <p>Q&amp;A session following presentation on history &amp; general approaches for radiation, with focus on head/neck cancer, by Dr. Alex Lin, Assistant Professor of Radiation Oncology at the Univ. of Pennsylvania.</p </p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Lecture on history and general approaches for radiation, with specific attention to its role in post-operative treatment of head/neck cancer, by Dr. Alex Lin, Assistant Professor of Radiation Oncology at the Univ. of Pennsylvania.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Lecture on history and general approaches for radiation, with specific attention to its role in post-operative treatment of head/neck cancer, by Dr. Alex Lin, Assistant Professor of Radiation Oncology at the Univ. of Pennsylvania.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Drs. George Blumenschein of MD Anderson Cancer Center and Walter Curran of Emory University, reviewing management options for the range of treatment approaches for patients with stage IIIA N2, locally advanced NSCLC.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Drs. George Blumenschein of MD Anderson Cancer Center and Walter Curran of Emory University, reviewing management options for the range of treatment approaches for patients with stage IIIA N2, locally advanced NSCLC.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre;">Case discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, covering question of optimal treatment for patients with advanced NSCLC who are elderly or have a marginal performance status.<br /></span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre;">Case discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, covering question of optimal treatment for patients with advanced NSCLC who are elderly or have a marginal performance status.<br /></span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Mark Socinski, medical oncologist and leader of the Thoracic Oncology Program at Univ. of North Carolina, answers questions about what treatments to recommend after first line therapy for advanced NSCLC and when they should be pursued.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Mark Socinski, medical oncologist and leader of the Thoracic Oncology Program at Univ. of North Carolina, answers questions about what treatments to recommend after first line therapy for advanced NSCLC and when they should be pursued.</span></p>